Irbesartan and Hydrochlorothiazide

DRUG2 trials

Sponsors

Roxane Laboratories

Conditions

Hypertension

Unknown Phase

Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions

CompletedNCT01712126

Roxane LaboratoriesHypertension

Start: 2007-09-30End: 2007-09-30Updated: 2018-01-23

Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

CompletedNCT01712139

Roxane LaboratoriesHypertension

Start: 2007-09-30End: 2007-09-30Updated: 2018-01-23